Trying to figure out whether someone has Alzheimer's disease usually involves a battery of assessments—interviews, brain imaging, blood and cerebrospinal fluid tests. But, by then, it's probably already too late: memories have started slipping away, long established personality traits have begun subtly shifting.
New AI program analyzing speech patterns could predict likelihood of Alzheimer's disease retrieved 25 June 2024 from https://medicalxpress.com/news/2024-06-ai-speech-patterns-likelihood-alzheimer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jun 3, 2024Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trialA recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.
Read more »
Can Alzheimer's really be reversed, as a new documentary claims?Two people diagnosed with Alzheimer's claim to have conquered the disease through simple lifestyle changes.
Read more »
Few UK people likely to be suitable for new Alzheimer's drugs when they become availableFew people in the UK with early stage Alzheimer's disease are likely to be suitable for the latest drugs that aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.
Read more »
Few UK Alzheimer's patients suitable for new disease-modifying drugs, study findsFew people in the UK with early stage Alzheimer's disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.
Read more »
A new drug could slow Alzheimer's: But can patients get it?It's welcome news for Alzheimer's patients and their families: A Food and Drug Administration advisory panel unanimously recommended approval for Eli Lilly & Co.'s treatment donanemab.
Read more »
New Alzheimer's drug's potentially fatal side effects obscured by 'soothing acronym,' doctors saySeventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer's drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys.
Read more »